METYROSINE AND CARBIDOPA FOR TREATMENT OF HTN ASSOCIATED WITH PHEOCHROMOCYTOMA

甲酪氨酸和卡比多巴用于治疗与嗜铬细胞瘤相关的高血压

• 批准号: 3741456
• 负责人: THOMAS L DAVIS
• 金额: --
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3741456
• 关键词: antihypertensive agents; cardiovascular disorder chemotherapy; combination chemotherapy; dopamine agonists; drug adverse effect; enzyme inhibitors; extrapyramidal disorder; human subject; hypertension; medical complication; pheochromocytoma; tyrosine 3 monooxygenase

This is a treatment protocol for patients with recurrent pheochromocytoma. Subjects will be given a combination of metyrosine and carbidopa and extrapyramidal effects will be closely monitored.

这是一个治疗方案， 嗜铬细胞瘤受试者将被给予甲酪氨酸和 将密切监测卡比多巴和锥体外系效应。